Aphex BioCleanse Systems Reports 2021 Third Quarter Operational Results
Aphex BioCleanse Systems (OTCPK: SNST) announced its financial filing for Q3 2021, highlighting significant operational changes and a new patent issuance. The company completed a leadership overhaul aimed at strategic market growth and regulatory approvals for its Hy-IQ® Water product. Additionally, Aphex showcased its environmentally friendly cleaning solutions at the ASD Market Week convention. Chairman Tom Fitzgerald emphasized the company’s focus on product commercialization and sales generation, particularly for its recently integrated bioFOAM™ product line.
- New patent granted for Open-Cell Foam Biological Indicator, enhancing product portfolio.
- Leadership changes aimed at strategic growth and regulatory approval for Hy-IQ Water.
- Showcased products at ASD Market Week, expanding market visibility.
- None.
PITTSFORD, N.Y., Nov. 15, 2021 /PRNewswire/ -- Aphex BioCleanse Systems, Inc. (OTCPK: SNST) ("Aphex" or "the Company"), a cutting-edge cleaning and disinfection company offering zero-footprint environmental remediation products, and known for its highly acclaimed non-toxic and water-based disinfection product line, Hy-IQ® Water, today announced a filing of its required financial and disclosure reports with the OTC Pink reporting service for the quarter ending September 30, 2021.
Operational Highlights as of End of Third Quarter 2021
- Completed strategic changes in the Aphex executive leadership team and composition of its Board of Directors, renewing focus on strategic market development, seeking regulatory approvals and achieving operational success
- Received notice of issuance of a new patent (US 11,112,397) for Open-Cell Foam Biological Indicator for Bacteria Detection & Removal from Water or Air, and Methods of Use
- Exhibited at the ASD (Affordable Shopping Destination) Market Week convention where Scott Smith, Aphex's Chief Sustainability Officer and Founder of bioFOAM™, presented a keynote address on environmentally friendly consumer cleaning products
"The third quarter of 2021 was a transitional and pivotal quarter for Aphex, and I can happily share that we effectively used it to re-position the company for further success headed into the remainder of the year and 2022," said Tom Fitzgerald, Aphex's Chairman of the Board. "We are looking to continue on our path toward regulatory approval of the Hy-IQ cleaning solution, propelling our Company into final stages of product commercialization setting a clear path to sustained revenue with some of the largest global players in the space. Beyond that, we remain laser-focused on generating sales and leveraging the proven success of our newly acquired and integrated bioFOAM™ product line, led by Mr. Scott Smith, whom I have every bit of confidence in to take Aphex and BioFoam to the next level. "
To learn more about Aphex, visit www.aphexus.com.
About Aphex BioCleanse Systems, Inc.
Aphex BioCleanse Systems, Inc is the developer of the world's first proprietary non-alcohol, non-toxic, and hydrogen-based cleaning technology. The technology, called Hy-IQ® Water, has a unique method of cleaning that uses hydrogen ions. Learn more about Aphex at www.aphexus.com.
FDA Statement
The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Contact:
ShareholderInfo@aphexus.com
www.aphexus.com
Phone: 1-585-386-0990
Address:
Aphex BioCleanse Systems Inc.
1162 Pittsford Victor Road Ste 220
Pittsford, NY 14534
For Aphex media inquiries, please contact:
Kathryn Brown
aphex@cmwmedia.com
858-264-6600
www.cmwmedia.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/aphex-biocleanse-systems-reports-2021-third-quarter-operational-results-301423418.html
SOURCE Aphex BioCleanse Systems Inc.
FAQ
What are the Q3 2021 financial results for SNST?
What is the significance of the new patent issued to SNST?
What leadership changes occurred at SNST?
Where did SNST present its products recently?